BACKGROUND A study was undertaken to investigate the pathogenesis of pulmonary involvement in human T lymphotropic virus type I (HTLV-I) carriers. METHODS The bronchoalveolar lavage (BAL) cell profile of 30 HTLV-I carriers (15 asymptomatic HTLV-I carriers (AHCs) and 15 symptomatic HTLV-I carriers (SHCs)) with chronic inflammatory diseases of respiratory tract and eight patients with HTLV-I as...

Human T-cell leukemia virus-1 (HTLV-1) is the first pathogenic human retrovirus discovered in 1980. HTLV-1 causes 2 devastating diseases: adult T-cell leukemia/lymphoma (ATL) and a neurological disorder, HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP or, more briefly, HAM). ATL becomes apparent in 2% to 5% of those infectedwithHTLV-1; another 1% to 2%will develop HAM. There ...

It is thought that human T-cell lymphotropic virus type I (HTLV-I) preferentially infects CD41 T cells in vivo. However, observations of high HTLV-I proviral load in patients with HTLV-I–associated myelopathy/tropical spastic paraparesis suggest that HTLV-I may infect other cell types in addition to CD41 T cells. To identify in vivo T-cell tropisms of HTLV-I, real-time quantitative polymerase c...

BACKGROUND Retroviruses of human T-lymphotropic viruses (HTLV-1 and HTLV-2) have been demonstrated to be endemic in the north-eastern region of Iran. This study was aimed to determine the HTLV-1 and HTLV-2 prevalence among healthy individuals in Neyshabur City during 2010-2014. METHODS A total of 8054 blood samples were collected from healthy participants in Neyshabur, North-Eastern Iran. The...

The association of human T-lymphotropic virus type I (HTLV-I) with autoimmune disorders was investigated on the basis of prevalence of antinuclear antibody (ANA), rheumatoid factor and anti-thyroglobulin antibody as well as immunoglobulin (Ig) serum level (IgG, IgA, and IgM). The subjects, all atomic bomb survivors, were 59 HTLV-I-seropositive people without HTLV-I-associated myelopathy or adul...

Crusted scabies, formerly known as Norwegian scabies is uncommon presentation of that may occur in the association with an immunosuppressive status. The article aims to present a case report which male patient HTLV-1 carrier status admitted for investigation eczematous and crusted chronic skin lesions submitted dermatologic evaluation biopsy considering hypothesis cutaneous form lymphoma associ...

objective: the aim of this study was to investigate the existence of human t-lymphotropic virus type 1 (htlv-1) in subgingival plaque of htlv-1 seropositive pa-tients. materials and methods: a total of 18 patients including 13 females and fivemales, with a mean age of 37 years participated in this descriptive study. half of them were htlv-1 carriers and the others were in htlv-1 associated myel...

Previously we showed that mononuclear cells from about half of human T-lymphotropic virus (HTLV)-seropositive persons exhibit spontaneous proliferation in vitro. We sought to determine if proliferation was associated with other immunologic changes characteristic of HTLV infection. The parameters assessed were (1) percentages of lymphocytes expressing CD4 and/or CD25 (interleukin-2 receptor), (2...

OBJECTIVE Hospital and laboratory data indicate that human T-lymphotropic virus type 1 (HTLV-1) is endemic to central Australia, but no community-based studies of its prevalence or disease burden have been reported. We determined the prevalence rates of HTLV-1 infection and of HTLV-1-associated diseases in a remote Indigenous community. SETTING A remote Northern Territory community. DESIGN ...

BACKGROUND HTLV-I infection has been linked to lung pathology and HTLV-II has been associated with an increased incidence of pneumonia and acute bronchitis. However it is unknown whether HTLV-I or -II infection alters pulmonary function. METHODS We performed pulmonary function testing on HTLV-I, HTLV-II and HTLV seronegative subjects from the HTLV outcomes study (HOST), including vital capaci...